Contineum Therapeutics CTNM
NASDAQ CTNM
$8.39 -0.07 (-0.83%)
As of: Oct 21, 2026 · 3:34 PM EDT

Contineum Therapeutics (CTNM) Asset Utilization Ratio (2024)

Updated

Contineum Therapeutics' (CTNM) Asset Utilization Ratio stood at 0.29 in Q2 2024.

Analysis

Contineum Therapeutics (CTNM) Asset Utilization Ratio (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,137.26 Bn 1,105.84 Bn 19.71 Bn 0.62
2 Johnson & Johnson 618.12 Bn 536.65 Bn 17.26 Bn 0.49
3 AbbVie 503.25 Bn 476.36 Bn 12.70 Bn 0.47
4 Merck 368.28 Bn 322.66 Bn 12.21 Bn 0.52
5 Novartis Ag 298.45 Bn 262.44 Bn 11.24 Bn 0.46
6 Astrazeneca 261.39 Bn 235.08 Bn 12.86 Bn 0.51
7 Amgen 237.30 Bn 192.70 Bn 7.24 Bn 0.40
8 Gilead Sciences 191.35 Bn 165.55 Bn 6.22 Bn 0.58
9 Pfizer 169.92 Bn 116.56 Bn 10.94 Bn 0.31
10 Contineum Therapeutics 311.55 Mn -616.64 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 0.29
API Access

Contineum Therapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=CTNM&period=max&api_key=YOUR_API_KEY